Literature DB >> 23111584

Increased red blood cell deformability and decreased aggregation as potential adaptive mechanisms in the slow coronary flow phenomenon.

Yalin Tolga Yaylali1, Ibrahim Susam, Erdem Demir, Melek Bor-Kucukatay, Burcu Uludag, Emine Kilic-Toprak, Gulten Erken, Dursun Dursunoglu.   

Abstract

OBJECTIVE: At present, the precise pathophysiology of the slow coronary flow phenomenon (SCFP) is still unknown and there is no consensus as to how it should be treated. The rheological factors affect the clinical course of various cardiovascular diseases. We studied the intrinsic properties of blood in the SCFP.
MATERIALS AND METHODS: Twenty-six SCFP patients who had angiographically confirmed SCFP, and had otherwise normal epicardial coronary arteries, were included in our study, as were 30 healthy individuals with normal results from arteriography. Red blood cell (RBC) deformability, aggregation, whole-blood viscosity at both native and standard (40%) hematocrit, and plasma viscosity were determined in each individual. The results were analyzed using a Mann-Whitney U-test, an unpaired t-test, and a χ-test, where appropriate.
RESULTS: The mean thrombolysis in myocardial infarction frame count was significantly higher in SCFP patients than in the controls. RBC deformability measured at five different shear rates was significantly higher in SCFP patients than in the controls. The RBC aggregation index was lower in SCFP patients. There were no statistically significant differences in RBC aggregation half-time (t1/2) and aggregation amplitude, whole-blood viscosity, and plasma viscosity between the two groups.
CONCLUSION: The SCFP is associated with increased RBC deformability and decreased RBC aggregation. These hemorheological alterations, possibly also contributing factors in limiting the pathogenesis, can especially serve as beneficial adaptive mechanisms in the SCFP.

Entities:  

Mesh:

Year:  2013        PMID: 23111584     DOI: 10.1097/MCA.0b013e32835b0bdf

Source DB:  PubMed          Journal:  Coron Artery Dis        ISSN: 0954-6928            Impact factor:   1.439


  7 in total

1.  Impaired Erythrocyte Deformability in Patients with Coronary Risk Factors: Significance of Nonvalvular Atrial Fibrillation.

Authors:  Keita Odashiro; Toru Maruyama; Taku Yokoyama; Hisataka Nakamura; Mitsuhiro Fukata; Shioto Yasuda; Kazuyuki Saito; Takehiko Fujino; Koichi Akashi
Journal:  J Atr Fibrillation       Date:  2013-10-31

2.  Influence of red blood cell aggregation on perfusion of an artificial microvascular network.

Authors:  Walter H Reinhart; Nathaniel Z Piety; Sergey S Shevkoplyas
Journal:  Microcirculation       Date:  2017-07       Impact factor: 2.628

3.  Interleukin-10 promotor -592A/C polymorphism is associated with slow coronary flow in Han Chinese.

Authors:  Gui-Liang Shi; Xing-Xing Cai; Ya-Min Su; Chu Chen; Xin-Tao Deng; Hai-Yan Pan; Meng-Kan Fan; Jian-Hua Zhu; Min Pan
Journal:  Int J Clin Exp Pathol       Date:  2015-04-01

4.  Platelet Activation in Ocular Behçet's Patients with Posterior Segment Involvement.

Authors:  Mehmet Citirik; Pinar C Ozdal; Ali Keles; Ibrahim C Haznedaroglu
Journal:  Middle East Afr J Ophthalmol       Date:  2022-04-30

5.  HEMOGLOBIN A1c LEVEL HIGHER THAN 9.05% CAUSES A SIGNIFICANT IMPAIRMENT OF ERYTHROCYTE DEFORMABILITY IN DIABETES MELLITUS.

Authors:  Q Li; L Z Yang
Journal:  Acta Endocrinol (Buchar)       Date:  2018 Jan-Mar       Impact factor: 0.877

6.  The Association between Whole Blood Viscosity and Coronary Collateral Circulation in Patients with Chronic Total Occlusion.

Authors:  Mehmet Serkan Cetin; Elif Hande Ozcan Cetin; Kevser Gülcihan Balcı; Selahattin Aydin; Emek Ediboglu; Muhammed Fatih Bayraktar; Mustafa Mücahit Balcı; Orhan Maden; Ahmet Temizhan; Sinan Aydogdu
Journal:  Korean Circ J       Date:  2016-11-01       Impact factor: 3.243

7.  The effect of blood cell count on coronary flow in patients with coronary slow flow phenomenon.

Authors:  Korhan Soylu; Okan Gulel; Huriye Yucel; Serkan Yuksel; Gokhan Aksan; Ayşegül İdil Soylu; Sabri Demircan; Ozcan Yılmaz; Mahmut Sahin
Journal:  Pak J Med Sci       Date:  2014-09       Impact factor: 1.088

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.